Vitamin D regulates human ectocervical epithelial cell proliferation and insulin-like growth factor-binding protein-3 level

被引:10
作者
Agarwal, C
Lambert, A
Chandraratna, RAS
Rorke, EA
Eckert, RL
机构
[1] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Dermatol, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Reprod Biol, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Sch Med, Dept Environm Hlth Sci, Cleveland, OH 44106 USA
[6] Allergan Pharmaceut Inc, Dept Chem, Irvine, CA 92713 USA
[7] Allergan Pharmaceut Inc, Dept Biol, Irvine, CA 92713 USA
关键词
D O I
10.1095/biolreprod60.3.567
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The differentiation status of the cervical epithelial cell has an important influence on responsiveness to estrogens and progestins, Several agents, including glucocorticoids and retinoids, are known to influence cervical cell differentiation. However, the effects of vitamin D have not been examined. Vitamin D is known to regulate cell proliferation and gene expression in a variety of epithelial cells. In the present study we investigated the ability of 1 alpha 25-dihydroxyvitamin D-3 (D3) to regulate cell proliferation and expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in human ectocervical epithelial cells. ECE16-1, a non-tumorigenic cervical cell line, was growth inhibited by D3 with maximal inhibition at 1000 nM. IGFBP-3 levels increased in parallel with the growth inhibition. IGFBP-3 levels were half-maximally increased at approximately 10-100 nM and maximally increased (10- to 30-fold) at 1000 nM D3. These studies show that vitamin D regulates cervical epithelial cell gene regulation and cell proliferation and that IGFBP-3 may be an in vivo marker of vitamin D action in the cervix.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 53 条
  • [1] AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells
    Agarwal, C
    Chandraratna, RAS
    Johnson, AT
    Rorke, EA
    Eckert, RL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) : 12209 - 12212
  • [2] AGARWAL C, 1994, CANCER RES, V54, P2108
  • [3] Agarwal C, 1996, CELL GROWTH DIFFER, V7, P521
  • [4] AGARWAL C, 1991, CANCER RES, V51, P3982
  • [5] BIOLOGICAL EVALUATION OF EPOXY ANALOGS OF 1-ALPHA,25-DIHYDROXYVITAMIN-D-3
    ALLEWAERT, K
    ZHAO, XY
    ZHAO, J
    GLIBERT, F
    BRANISTEANU, D
    DECLERCQ, P
    VANDEWALLE, M
    BOUILLON, R
    [J]. STEROIDS, 1995, 60 (04) : 324 - 332
  • [6] ANZANO MA, 1994, CANCER RES, V54, P1653
  • [7] BATOVA A, 1992, CELL GROWTH DIFFER, V3, P763
  • [8] INSULIN-LIKE GROWTH FACTOR-I (IGF-I)-BINDING PROTEIN COMPLEX IS A BETTER MITOGEN THAN FREE IGF-I
    BLUM, WF
    JENNE, EW
    REPPIN, F
    KIETZMANN, K
    RANKE, MB
    BIERICH, JR
    [J]. ENDOCRINOLOGY, 1989, 125 (02) : 766 - 772
  • [9] TOPICAL CALCIPOTRIOL TREATMENT IN ADVANCED BREAST-CANCER
    BOWER, M
    COLSTON, KW
    STEIN, RC
    HEDLEY, A
    GAZET, JC
    FORD, HT
    COOMBES, RC
    [J]. LANCET, 1991, 337 (8743) : 701 - 702
  • [10] THE ANTIPROLIFERATIVE EFFECT OF VITAMIN-D ANALOGS ON MCF-7 HUMAN BREAST-CANCER CELLS
    BRENNER, RV
    SHABAHANG, M
    SCHUMAKER, LM
    NAUTA, RJ
    USKOKOVIC, MR
    EVANS, SRT
    BURAS, RR
    [J]. CANCER LETTERS, 1995, 92 (01) : 77 - 82